Autolus Therapeutics plc ADR (NASDAQ:AUTL) price on current trading day, rose 1.68% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.82.
A look at the stock’s price movement, the close in the last trading session was $1.79. Turning to its 52-week performance, $6.62 and $1.79 were the 52-week high and 52-week low respectively. Overall, AUTL moved -19.47% over the past month.
Autolus Therapeutics plc ADR’s market cap currently stands at around $484.34 million, with investors looking forward to this quarter’s earnings report slated for in March.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 17.33M, representing a 920.38% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AUTL is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend AUTL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AUTL’s current price about -9.63% and -17.91% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.09, while 7-day volatility ratio is 4.91% and 5.60% in the 30-day chart. Further, Autolus Therapeutics plc ADR (AUTL) has a beta value of 2.06, and an average true range (ATR) of 0.12. Analysts have given the company’s stock an average 52-week price target of $7.6, forecast between a low of $7.6 and high of $7.6. Looking at the price targets, the low is -317.58% off current price level while to achieve the yearly target high, price needs to move -317.58%. Nonetheless, investors will most likely welcome a -317.58% jump to $7.6 which is the analysts’ median price.
If we refocus on Autolus Therapeutics plc ADR (NASDAQ:AUTL), historical trading data shows that trading volumes averaged 1.39 million over the past 3 months. The company’s latest data on shares outstanding shows there are 266.12 million shares.
The 9.70% of Autolus Therapeutics plc ADR’s shares are in the hands of company insiders while institutional holders own 53.78% of the company’s shares. Current price change has pushed the stock -22.55% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AUTL stock continues to rise going into the next quarter.
